nb100-56160pep Search Results


anti tlr2 peptide  (Novus Biologicals)
90
Novus Biologicals anti tlr2 peptide
Anti Tlr2 Peptide, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti tlr2 peptide/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
anti tlr2 peptide - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
tlr4 blocking antibodies  (Novus Biologicals)
90
Novus Biologicals tlr4 blocking antibodies
( A ) MDMs were treated with TLR2 agonist (Pam3CSK4, 1 µg/ml), <t>TLR4</t> agonist (MPLA, 1 µg/ml) and TLR9 agonist (ODN2006, 10 µg/ml) for 9 h. As a control, MDMs were also treated with γ- Mtb H37Rv (10 µg/ml). Cell surface TF activity was determined in factor X activation assay.* indicates significant difference compared to untreated cells (P≤0.01); # denotes significant difference compared to γ- Mtb treated cells (P<0.01) ( B ) MDMs were preincubated with CD14, TLR2 and TLR4 blocking antibodies (each, 10 µg/ml) either alone or in combination and with isotype control IgG for 45 min at 37°C and then cells were stimulated with γ- Mtb for 9 h. At the end of the stimulation period cell surface TF activity was measured in factor X activation assay. # denotes significant inhibition compared to γ- Mtb or LPS alone treated cells (P<0.05); paired t-test. Data are mean ± SEM (n = 3–8).
Tlr4 Blocking Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tlr4 blocking antibodies/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
tlr4 blocking antibodies - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
monoclonal sars nucleocapsid protein antibody  (Novus Biologicals)
90
Novus Biologicals monoclonal sars nucleocapsid protein antibody
( A ) MDMs were treated with TLR2 agonist (Pam3CSK4, 1 µg/ml), <t>TLR4</t> agonist (MPLA, 1 µg/ml) and TLR9 agonist (ODN2006, 10 µg/ml) for 9 h. As a control, MDMs were also treated with γ- Mtb H37Rv (10 µg/ml). Cell surface TF activity was determined in factor X activation assay.* indicates significant difference compared to untreated cells (P≤0.01); # denotes significant difference compared to γ- Mtb treated cells (P<0.01) ( B ) MDMs were preincubated with CD14, TLR2 and TLR4 blocking antibodies (each, 10 µg/ml) either alone or in combination and with isotype control IgG for 45 min at 37°C and then cells were stimulated with γ- Mtb for 9 h. At the end of the stimulation period cell surface TF activity was measured in factor X activation assay. # denotes significant inhibition compared to γ- Mtb or LPS alone treated cells (P<0.05); paired t-test. Data are mean ± SEM (n = 3–8).
Monoclonal Sars Nucleocapsid Protein Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal sars nucleocapsid protein antibody/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
monoclonal sars nucleocapsid protein antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bcl-2 antibody blocking peptide  (Novus Biologicals)
N/A
Bcl-2 Antibody Blocking Peptide
   Buy from Supplier
nalp4 antibody blocking peptide  (Novus Biologicals)
N/A
NALP4 Antibody Blocking Peptide
   Buy from Supplier
nlrp1/nalp1 antibody blocking peptide  (Novus Biologicals)
N/A
NLRP1/NALP1 Antibody Blocking Peptide
   Buy from Supplier
tlr4 antibody blocking peptide  (Novus Biologicals)
N/A
TLR4 Antibody Blocking Peptide
   Buy from Supplier
traf-4 antibody blocking peptide  (Novus Biologicals)
N/A
TRAF-4 Antibody Blocking Peptide
   Buy from Supplier
traf3ip2 antibody blocking peptide  (Novus Biologicals)
N/A
TRAF3IP2 Antibody Blocking Peptide
   Buy from Supplier
xiap antibody blocking peptide  (Novus Biologicals)
N/A
XIAP Antibody Blocking Peptide
   Buy from Supplier
daxx antibody blocking peptide  (Novus Biologicals)
N/A
Daxx Antibody Blocking Peptide
   Buy from Supplier
nod1 antibody blocking peptide  (Novus Biologicals)
N/A
NOD1 Antibody Blocking Peptide
   Buy from Supplier

Image Search Results


( A ) MDMs were treated with TLR2 agonist (Pam3CSK4, 1 µg/ml), TLR4 agonist (MPLA, 1 µg/ml) and TLR9 agonist (ODN2006, 10 µg/ml) for 9 h. As a control, MDMs were also treated with γ- Mtb H37Rv (10 µg/ml). Cell surface TF activity was determined in factor X activation assay.* indicates significant difference compared to untreated cells (P≤0.01); # denotes significant difference compared to γ- Mtb treated cells (P<0.01) ( B ) MDMs were preincubated with CD14, TLR2 and TLR4 blocking antibodies (each, 10 µg/ml) either alone or in combination and with isotype control IgG for 45 min at 37°C and then cells were stimulated with γ- Mtb for 9 h. At the end of the stimulation period cell surface TF activity was measured in factor X activation assay. # denotes significant inhibition compared to γ- Mtb or LPS alone treated cells (P<0.05); paired t-test. Data are mean ± SEM (n = 3–8).

Journal: PLoS ONE

Article Title: Mycobacterium tuberculosis Infection and Tissue Factor Expression in Macrophages

doi: 10.1371/journal.pone.0045700

Figure Lengend Snippet: ( A ) MDMs were treated with TLR2 agonist (Pam3CSK4, 1 µg/ml), TLR4 agonist (MPLA, 1 µg/ml) and TLR9 agonist (ODN2006, 10 µg/ml) for 9 h. As a control, MDMs were also treated with γ- Mtb H37Rv (10 µg/ml). Cell surface TF activity was determined in factor X activation assay.* indicates significant difference compared to untreated cells (P≤0.01); # denotes significant difference compared to γ- Mtb treated cells (P<0.01) ( B ) MDMs were preincubated with CD14, TLR2 and TLR4 blocking antibodies (each, 10 µg/ml) either alone or in combination and with isotype control IgG for 45 min at 37°C and then cells were stimulated with γ- Mtb for 9 h. At the end of the stimulation period cell surface TF activity was measured in factor X activation assay. # denotes significant inhibition compared to γ- Mtb or LPS alone treated cells (P<0.05); paired t-test. Data are mean ± SEM (n = 3–8).

Article Snippet: TLR2 and TLR4 blocking antibodies were from Imgenex Corp. (San Diego, CA).

Techniques: Control, Activity Assay, Activation Assay, Blocking Assay, Inhibition